Candel Therapeutics Inc (CADL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 8,757 | 8,571 | 7,902 | 10,318 | 8,861 |
| Operating Income | -8,757 | -8,571 | -7,902 | -10,318 | -8,861 |
| Interest Expense | 487 | 567 | 646 | 673 | 669 |
| Other Income | -1,402 | -13,099 | 327 | -104 | 1,095 |
| Pre-tax Income | -10,646 | -22,237 | -8,221 | -11,095 | -8,435 |
| Net Income Continuous | -10,646 | -22,237 | -8,221 | -11,095 | -8,435 |
| Net Income | $-10,646 | $-22,237 | $-8,221 | $-11,095 | $-8,435 |
| EPS Basic Total Ops | -0.33 | -0.74 | -0.28 | -0.39 | -0.29 |
| EPS Basic Continuous Ops | -0.33 | -0.74 | -0.28 | -0.38 | -0.29 |
| EPS Diluted Total Ops | -0.33 | -0.74 | -0.28 | -0.39 | -0.29 |
| EPS Diluted Continuous Ops | -0.33 | -0.74 | -0.28 | -0.38 | -0.29 |
| EPS Diluted Before Non-Recurring Items | -0.33 | -0.74 | -0.28 | N/A | N/A |
| EBITDA(a) | $-8,512 | $-8,322 | $-7,651 | $-10,069 | $-8,616 |